Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer

Clinical trial NCT03007979 · COMPLETED

Trial details

NCT number: NCT03007979
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Carcinoma Cancer of Breast Malignant Tumor of Breast

Start date: 2017-06-15
Primary completion: 2020-03-13
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.